Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Merck
Dow
McKinsey
Colorcon

Last Updated: May 26, 2022

Apothecon Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for APOTHECON, and what generic and branded alternatives to APOTHECON drugs are available?

APOTHECON has one hundred and fourteen approved drugs.



Summary for Apothecon
US Patents:0
Tradenames:78
Ingredients:47
NDAs:114

Drugs and US Patents for Apothecon

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon PROLIXIN fluphenazine hydrochloride TABLET;ORAL 011751-002 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing
Apothecon SUMYCIN tetracycline hydrochloride CAPSULE;ORAL 060429-004 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
Apothecon VESPRIN triflupromazine hydrochloride INJECTABLE;INJECTION 011325-004 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
Apothecon PRINCIPEN '500' ampicillin/ampicillin trihydrate CAPSULE;ORAL 062157-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Apothecon

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apothecon CAPOZIDE 25/25 captopril; hydrochlorothiazide TABLET;ORAL 018709-002 Oct 12, 1984 4,217,347 See Plans and Pricing
Apothecon KLOTRIX potassium chloride TABLET, EXTENDED RELEASE;ORAL 017850-001 Approved Prior to Jan 1, 1982 4,140,756 See Plans and Pricing
Apothecon STADOL PRESERVATIVE FREE butorphanol tartrate INJECTABLE;INJECTION 017857-001 Approved Prior to Jan 1, 1982 3,819,635 See Plans and Pricing
Apothecon CAPOZIDE 25/25 captopril; hydrochlorothiazide TABLET;ORAL 018709-002 Oct 12, 1984 4,105,776 See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Baxter
Mallinckrodt
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.